Merz wins $185m bid for bankrupt Acorda assets and increases US workforce by 50%
The deal strengthens Merz’s market position in Parkinson’s disease whilst expanding into the multiple sclerosis sector.
The deal strengthens Merz’s market position in Parkinson’s disease whilst expanding into the multiple sclerosis sector.
What's Your Reaction?
